ABSCI CORPORATION - COMMON STOCK
3.0150
14-November-24 16:45:00
15 minutes delayed
Stocks
-0.1250
-3.98%
Today's range
2.9500 - 3.2000
ISIN
N/A
Source
NASDAQ
-
06 Jun 2023 08:00:02 By Nasdaq GlobeNewswire
-
Absci Reports Business Updates and First Quarter 2023 Financial and Operating Results
15 May 2023 16:05:00 By Nasdaq GlobeNewswire
-
11 May 2023 08:00:01 By Nasdaq GlobeNewswire
-
Absci to Participate in the 22nd Annual Needham Virtual Healthcare Conference
06 Apr 2023 08:00:00 By Nasdaq GlobeNewswire
-
Absci Partners with Bioinformatics Company M2GEN to Accelerate Drug Creation for Oncology
04 Apr 2023 08:00:00 By Nasdaq GlobeNewswire
-
Absci Reports Fourth Quarter and Full Year 2022 Financial and Operating Results
30 Mar 2023 16:05:00 By Nasdaq GlobeNewswire
-
23 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
Absci to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
07 Mar 2023 08:00:01 By Nasdaq GlobeNewswire
-
28 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
Absci to Participate in the 43rd Annual Cowen Health Care Conference
21 Feb 2023 08:00:02 By Nasdaq GlobeNewswire
-
St. John’s Cancer Institute Partners with Absci to Expedite Development of Cancer Therapies
09 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
Absci Deepens Scientific Advisory Board to Accelerate Generative AI Drug Creation
08 Feb 2023 08:00:00 By Nasdaq GlobeNewswire
-
Absci First to Create and Validate De Novo Antibodies with Zero-Shot Generative AI
10 Jan 2023 08:00:02 By Nasdaq GlobeNewswire
-
Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference
08 Jan 2023 15:13:30 By Nasdaq GlobeNewswire
-
Absci to Participate in the 41st Annual J.P. Morgan Healthcare Conference
28 Dec 2022 08:00:00 By Nasdaq GlobeNewswire
-
Absci to Participate in the Berenberg Discover AI Seminar
23 Nov 2022 08:00:00 By Nasdaq GlobeNewswire
-
Absci to Participate in the Stifel Healthcare Conference
02 Nov 2022 16:05:01 By Nasdaq GlobeNewswire
-
Absci Welcomes Meta Senior Executive to Board of Directors
02 Nov 2022 08:00:01 By Nasdaq GlobeNewswire
-
Absci to Participate in the 31st Annual Credit Suisse Healthcare Conference
26 Oct 2022 08:00:01 By Nasdaq GlobeNewswire
-
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
04 Oct 2022 07:00:00 By Nasdaq GlobeNewswire